<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20231004059615N11</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2026-08-23</date_registration>
      <primary_sponsor>INTERNATIONAL SCIENCE AND TECHNOLOGY UNIVERSITY</primary_sponsor>
      <public_title>The effectiveness of caffeine for maximizing hypertrophy and strength in older adults.</public_title>
      <acronym></acronym>
      <scientific_title>The effectiveness of pre-exercise caffeine in maximizing hypertrophy and strength gains from morning resistance training in older adults</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2026-08-31</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>60</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/92684</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Double blinded, Placebo: Used, Assignment: Parallel, Purpose: Basic scienece, Randomization description: To minimize potential differences between groups, participants will first be grouped based on their average 1-repetition maximum strength in the squat and bench press. The names of the subjects in each group will be entered into an Excel column; each subject will be randomly assigned a number using the RAND function (=RAND()); then, the numbers will be sorted from smallest to largest. Subjects in each group will then be randomly assigned to one of three groups in a 1:1:1 fashion: caffeine and exercise in the morning, placebo and exercise in the morning, or placebo and exercise in the afternoon, Blinding description: Someone outside the study will prepare the supplement and placebo and will not be known to the participants or researchers until after the data analysis. Also, subjects will receive the supplement and placebo in an opaque capsule with a completely similar appearance and weight, and at the same time of day.</study_design>
      <phase>3</phase>
      <hc_freetext>Strength training adaptations.</hc_freetext>
      <i_freetext>Intervention 1: Intervention group 1: MOR-CAF, morning training (08:00) + pre-workout caffeine (4 mg/kg) + daily multi-ingredient supplementation  (whey protein, creatine monohydrate, and omega-3 PUFAs). Intervention 2: Intervention group 2: MOR-PLA, morning training (08:00) + pre-workout placebo + daily multi-ingredient supplementation  (whey protein, creatine monohydrate, and omega-3 PUFAs). Intervention 3: Control group: AFT-PLA, afternoon training (17:00) + pre-workout placebo + daily multi-ingredient supplementation  (whey protein, creatine monohydrate, and omega-3 PUFAs).</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Yes - There is a plan to make this available</results_IPD_plan>
      <results_IPD_description>What will be shared:
All data collected during the study will be shareable after de-identifying the subjects.

When:
The data will be published after the extracted articles are accepted.

To whom:
All people

Conditions:
All data collected during the study will be shareable after de-identifying the subjects. The requester will only be permitted to use the data for meta-analysis reviews.

Where to obtain:
Corresponding author: Davar Khodadadi, Faculty of Physical Education and Sports Sciences, Islamic Azad University Central Tehran Branch, Tehran, Iran. Email: davar.khodadadi@yahoo.com

How to obtain:
Sending an email request to the corresponding author: Davar Khodadadi, Email: davar.khodadadi@yahoo.com

Comments:
</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Davar Khodadadi</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Faculty of Physical Education and Sports Sciences, Velayat University Complex, Shahid Sohani St., Sohank</address>
        <city>Tehran</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>1955847781</zip>
        <telephone>+98 21 2263 3583</telephone>
        <email>davar.khodadadi@yahoo.com</email>
        <affiliation>Islamic Azad University</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Davar Khodadadi</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Faculty of Physical Education and Sports Sciences, Velayat University Complex, Shahid Sohani St., Sohank</address>
        <city>Tehran</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>1955847781</zip>
        <telephone>+98 21 2263 3583</telephone>
        <email>davar.khodadadi@yahoo.com</email>
        <affiliation>Islamic Azad University</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Turkey</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Low habitual caffeine intake (&lt;100 mg/day)
Recreationally active but unaccustomed to structured resistance training for the preceding 6 months
Not a smoker
Not an alcohol drinker</inclusion_criteria>
      <agemin>65 years</agemin>
      <agemax>80 years</agemax>
      <gender>Both</gender>
      <exclusion_criteria>Have uncontrolled cardiovascular, metabolic, or respiratory disease
Have severe osteoarthritis
Have sleep disorders
Current use of medications known to alter neuromuscular function or sleep architecture</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code></hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword></hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Lifestyle</i_code>
      <i_code>Lifestyle</i_code>
      <i_code>Placebo</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group 1: MOR-CAF, morning training (08:00) + pre-workout caffeine (4 mg/kg) + daily multi-ingredient supplementation  (whey protein, creatine monohydrate, and omega-3 PUFAs)</i_keyword>
      <i_keyword>Intervention group 2: MOR-PLA, morning training (08:00) + pre-workout placebo + daily multi-ingredient supplementation  (whey protein, creatine monohydrate, and omega-3 PUFAs)</i_keyword>
      <i_keyword>Control group: AFT-PLA, afternoon training (17:00) + pre-workout placebo + daily multi-ingredient supplementation  (whey protein, creatine monohydrate, and omega-3 PUFAs)</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Body composition. Timepoint: Pre-test and post-test. Method of measurement: Using dual-energy X-ray absorptiometry.</prim_outcome>
      <prim_outcome>Skeletal muscle thickness. Timepoint: Pre-test and post-test. Method of measurement: Using an ultrasound instrument.</prim_outcome>
      <prim_outcome>Mascular strength. Timepoint: Pre-test and post-test. Method of measurement: Using one-repetition maximum test based on the standardized NSCA protocols.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome>Cumulative training volume-load. Timepoint: During the intervention period (all training sessions). Method of measurement: Calculated as the sum of lifted load using the formula (kilograms × repetitions × sets) accumulated during each training session.</sec_outcome>
      <sec_outcome>Sleep quality. Timepoint: Pre-test and post-test. Method of measurement: By the Pittsburgh Sleep Quality Index (PSQI).</sec_outcome>
      <sec_outcome>Sleep efficiency. Timepoint: Pre-test and post-test. Method of measurement: By wrist-worn actigraphy.</sec_outcome>
      <sec_outcome>Functional physical performance. Timepoint: Pre-test and post-test. Method of measurement: Using the Short Physical Performance Battery (SPPB).</sec_outcome>
      <sec_outcome>Muscular endurance. Timepoint: Pre-test and post-test. Method of measurement: By a repetitions-to-failure test on the back squat using a load corresponding to 50% of 1RM.</sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>INTERNATIONAL SCIENCE AND TECHNOLOGY UNIVERSITY</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2026-08-12</approval_date>
        <contact_name>Ethics Committee of the International Science and Technology University</contact_name>
        <contact_address>Tunahan Mah. Dumlupinar 30 Agustos Cad. No:2, Metromal Business F Blok Office Ankara Ankara Turkey</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
